{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:00:18Z","timestamp":1777532418344,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ahj.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:28:56Z","timestamp":1659590936000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial"],"prefix":"10.1016","volume":"254","author":[{"given":"Stephen Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajesh","family":"Gongal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyere K.","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2022.07.006_bib0001","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.07.006_bib0002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.0000165310.84801.e0","article-title":"Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults","volume":"46","author":"McEniery","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2022.07.006_bib0003","article-title":"Isolated diastolic hypertension and risk of cardiovascular events: a systematic review and meta-analysis of cohort studies with 489,814 participants","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2022.07.006_bib0004","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1751-7176.2010.00266.x","article-title":"Hypothesis: it is time to reconsider phenotypes in hypertension","volume":"12","author":"Orias","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ahj.2022.07.006_bib0005","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"Furberg","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.07.006_bib0006","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2022.07.006_bib0007","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2003.11.029","article-title":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study","volume":"43","author":"Julius","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.07.006_bib0008","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.07.006_bib0009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jash.2014.08.003","article-title":"Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT","volume":"8","author":"Yamal","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.ahj.2022.07.006_bib0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2022.07.006_bib0011","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/jch.14296","article-title":"Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)","volume":"23","author":"Vakil","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ahj.2022.07.006_bib0012","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2019.7454","article-title":"Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension","volume":"180","author":"Hripcsak","year":"2020","journal-title":"JAMA Int Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T13:02:18Z","timestamp":1672059738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322001570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":12,"alternative-id":["S0002870322001570"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.07.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}